ArticleCancers2022

Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Hiroaki Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.